Leavell Investment Management Inc. Acquires 661 Shares of Abbott Laboratories (NYSE:ABT)

Leavell Investment Management Inc. lifted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% in the first quarter, according to its most recent filing with the SEC. The firm owned 36,851 shares of the healthcare product maker’s stock after acquiring an additional 661 shares during the period. Leavell Investment Management Inc.’s […]

Related Keywords

Canada , Roberte Funck , Raymond James , Wealthplan Investment Management , Barclays , Sageview Advisory Group , Leavell Investment Management Inc , Abbott Laboratories , Citigroup , Compass Ion Advisors , Royal Bank , Wealth Advisors , Leavell Investment Management , Free Report , Investment Management , Plan Investment Management , Ion Advisors , View Advisory Group , Laboratories Trading Down , Get Free Report , Gesua Sive Salvadori , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Abbott Laboratories Daily ,